• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY SYNERGY¿; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY SYNERGY¿; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number H7493926238350
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Perforation of Vessels (2135); Cardiac Tamponade (2226)
Event Date 05/04/2018
Event Type  Injury  
Manufacturer Narrative
Device is a combination product.Device evaluated by mfr: it is indicated that the device will not be returned for evaluation.If there is any further relevant information obtained, a supplemental medwatch will be filed.(b)(4).
 
Event Description
Same case as mdr id: 2134265-2018-04654, 2134265-2018-04655, 2134265-2018-04646, 2134265-2018-04647, 2134265-2018-04659, 2134265-2018-04660.It was reported that vessel perforation and cardiac tamponade occurred.The patient presented with diffused calcification and narrowing of the left main (lm), left anterior descending (lad) and left circumflex (lcx); severe left ventricle (lv) dysfunction and aortic stenosis.This procedure was planned prior to an a transcatheter aortic valve implantation.Pre-dilation was completed with emerge¿ balloon catheters.Then three synergy¿ stents were implanted (4 x 24, 4 x 28 and a 3.5 x 38) were implanted.The stents were post dilated with nc emerge® balloon catheters.After post dilatation, a perforation was noted at the bifurcation of the lad and lcx.The perforation was treated by deploying non-bsc stents and further post dilatation of those stents.The perforation caused cardiac tamponade and pericardiocentesis was performed; a significant amount of blood was drained.The patient was stable prior to transfer to the intensive care unit.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY¿
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
Manufacturer (Section G)
BOSTON SCIENTIFIC - GALWAY
Manufacturer Contact
sonali arangil
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key7506041
MDR Text Key107961642
Report Number2134265-2018-04656
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeAU
PMA/PMN Number
SIMILAR
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 05/04/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/11/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date02/25/2019
Device Model NumberH7493926238350
Device Catalogue Number39262-3835
Device Lot Number21098180
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/04/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/19/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age92 YR
-
-